Clinical Trial Update: Jafron Haemoadsorption During Cardiopulmonary Bypass [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Jafron haemoadsorption during cardiopulmonary bypass in patients with Cytokine Release Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Release Syndrome

Drugs mentioned

• Jafron haemoadsorption (haemoadsorption)

Snippet

Sponsor: Anthea Hospital Bari | Conditions: Cytokine Release Syndrome | Phase 2 | Status: COMPLETED